We are live on ! Find out more
AVDL

Avadel Pharmaceuticals
AVDL

Delisted

AVDL was delisted on the 11th of February, 2026.

Back to rankings

52 hedge funds and large institutions have $299M invested in Avadel Pharmaceuticals in 2014 Q1 according to their latest regulatory filings, with 23 funds opening new positions, 15 increasing their positions, 7 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

300% more funds holding in top 10

Funds holding in top 10: 1 → 4 (+3)

283% more first-time investments, than exits

New positions opened: 23 | Existing positions closed: 6

271% more capital invested

Capital invested by funds: $80.5M → $299M (+$218M)

114% more repeat investments, than reductions

Existing positions increased: 15 | Existing positions reduced: 7

49% more funds holding

Funds holding: 35 → 52 (+17)

12% more call options, than puts

Call options by funds: $925K | Put options by funds: $825K

Holders
52
Holders Change
+17
Holders Change %
+48.57%
% of All Funds
1.5%
Holding in Top 10
4
Holding in Top 10 Change
+3
Holding in Top 10 Change %
+300%
% of All Funds
0.12%
New
23
Increased
15
Reduced
7
Closed
6
Calls
$925K
Puts
$825K
Net Calls
+$100K
Net Calls Change
+$92K

Top Buyers

Rank Fund Capital Flow
1
JP Morgan Chase
JP Morgan Chase
New York
+$16.2M
2
BC
Broadfin Capital
New York
+$16.1M
3
Jennison Associates
Jennison Associates
New York
+$16.1M
4
Millennium Management
Millennium Management
New York
+$11.6M
5
CCM
Consonance Capital Management
New York
+$11.2M

Top Sellers

Rank Fund Capital Flow
1
Invesco
Invesco
Georgia
-$631K
2
IAM
Iridian Asset Management
Connecticut
-$582K
3
CCI
Columbus Circle Investors
-$468K
4
BCM
Bourgeon Capital Management
Connecticut
-$193K
5
VKH
Virtu KCG Holdings
New York
-$116K
Name Holding Trade Value Shares
Change 		Change in
Stake
BC
1
Broadfin Capital
New York
$70.6M +$16.1M +1,500,000 +40%
DM
2
Deerfield Management
New York
$70.5M +$9.91M +925,000 +21%
JP Morgan Chase
3
JP Morgan Chase
New York
$20.3M +$16.2M +1,514,499 New
Jennison Associates
4
Jennison Associates
New York
$20.1M +$16.1M +1,500,000 New
Millennium Management
5
Millennium Management
New York
$16.9M +$11.6M +1,080,910 +598%
CCM
6
Consonance Capital Management
New York
$14M +$11.2M +1,047,576 New
PA
7
Perceptive Advisors
New York
$10.7M +$8.57M +800,000 New
RSCM
8
Rock Springs Capital Management
Maryland
$10.1M +$8.04M +750,000 New
VM
9
VHCP Management
New York
$6.7M +$5.36M +500,000 New
Fidelity Investments
10
Fidelity Investments
Massachusetts
$6.61M +$5.29M +493,361 New
BCM
11
Brown Capital Management
Maryland
$6.6M +$9.8K +914 +0.2%
Alyeska Investment Group
12
Alyeska Investment Group
Illinois
$6.4M +$5.12M +477,636 New
KCM
13
Kennedy Capital Management
Missouri
$6M +$4.8M +447,496 New
Morgan Stanley
14
Morgan Stanley
New York
$4.78M +$2.86M +266,679 +296%
Bank of New York Mellon
15
Bank of New York Mellon
New York
$4.68M +$567K +52,876 +18%
GTC
16
Ghost Tree Capital
New York
$4.02M +$1.93M +180,000 +150%
WMSA
17
Weiss Multi-Strategy Advisers
New York
$3.89M +$3.11M +290,000 New
WC
18
Wexford Capital
Florida
$2.21M +$1.77M +165,000 New
Deutsche Bank
19
Deutsche Bank
Germany
$1.89M +$1.39M +129,812 +1,159%
IAM
20
Iridian Asset Management
Connecticut
$1.38M -$582K -54,310 -35%
Neuberger Berman Group
21
Neuberger Berman Group
New York
$1.03M +$825K +77,000 New
OAM
22
Oxford Asset Management
United Kingdom
$992K +$794K +74,053 New
BIM
23
Bogle Investment Management
Massachusetts
$959K +$767K +71,593 New
U
24
UBS
Switzerland
$947K +$2.7K +252 +0.4%
California Public Employees Retirement System
25
California Public Employees Retirement System
California
$924K – – –
1
2 3

AVDL Hedge Fund Activity: Q1 2014 in Review

52 of the 3,464 institutional investors tracked by Wall St. Rank reported a position in Avadel Pharmaceuticals (AVDL) for Q1 2014, worth a combined $299M — up 271% from $80.5M a quarter earlier.

Buyers outnumbered sellers: 23 funds opened new AVDL positions and 6 closed out — a net gain of 17 holders — while 15 added to existing stakes and 7 trimmed.

The largest buyer was JP Morgan Chase, opening a new position worth an estimated $16.2M. The largest seller was Invesco, exiting entirely with an estimated $631K sold.

  • 52 institutional investors held Avadel Pharmaceuticals (AVDL) as of Q1 2014, up from 35 in Q4 2013.
  • Funds reported $299M of Avadel Pharmaceuticals stock for Q1 2014, up 271% quarter-over-quarter.
  • 23 funds opened new Avadel Pharmaceuticals positions in Q1 2014 and 6 closed out, a net change of +17 holders.
  • The largest Avadel Pharmaceuticals buyer in Q1 2014 was JP Morgan Chase, an estimated $16.2M added.
  • The largest Avadel Pharmaceuticals seller in Q1 2014 was Invesco, an estimated $631K sold.

Based on aggregated 13F filings for Q1 2014.